Changzhou Qianhong Biopharma Co Ltd (002550.SZ) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · China · ISIN CNE100001070
Changzhou Qianhong Biopharma Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 1.53 bn CNY | 1.57 bn CNY |
| Gross profit | 829.94 m CNY | 916.93 m CNY |
| Operating income | 396.39 m CNY | 332.51 m CNY |
| EBIT | 282.12 m CNY | 450.64 m CNY |
| Net income | 356.03 m CNY | 398.80 m CNY |
| Diluted EPS – continuing operations | 0.28 CNY | 0.31 CNY |
Full history since 2007, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Changzhou Qianhong Biopharma Co Ltd
Changzhou Qianhong Biopharma CO.,LTD manufactures and distributes polysaccharide and protease drugs in China. The company offers heparin sodium, heparin calcium, enoxaparin sodium, dalteparin sodium, nadroparin calcium, pancreatin, heparinoid API, kallidinogenase, and asparaginase, as well as offers berry source and target diet box. It also provides low molecular weight heparin, compound digestive enzyme preparations, and health products. In addition, the company exports its products. The company was founded in 1971 and is headquartered in Changzhou, China.
More stocks
- Hyundai Development Co (294870.KS)
- Capitalonline Data Service Co Ltd (300846.SZ)
- MilDef Group AB (MILDEF.ST)
- Sparekassen Sjaelland-Fyn A/S (SPKSJF.CO)
- Shenzhen Desay Battery Technology Co Ltd (000049.SZ)
- Uniti Group Inc. (UNIT)
- Tower Bersama Infrastructure Tbk PT (TBIG.JK)
- Henan Thinker Automation (603508.SS)
- TUHU Car Inc (9690.HK)
- Ultra Jaya Milk Industry Tbk (ULTJ.JK)
- Galapagos NV (GLPG.AS)
- JETBLUE AIRWAYS CORP (JBLU)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.